Concepedia

Andrew Gibb

AG

Statistics

Publications

14

Citations

553

H-Index

13

Active since

2001

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Andrew Gibb is an author at MSD (UK) Limited (United Kingdom) specializing in synthetic medicinal chemistry, chemistry, and medicinal chemistry.

Publications per year

2001–2014

14

Publications

14

Catalytic, Asymmetric, and Stereodivergent Synthesis of Non-Symmetric β,β-Diaryl-α-Amino Acids

Carmela Molinaro, Jeremy P. Scott, Michael Shevlin et al. · Journal of the American Chemical Society · 2014 · 105 citations

, , +14

Regioselective Synthesis of 1,3,5-Substituted Pyrazoles from Acetylenic Ketones and Hydrazines

Brian Bishop, Karel M. J. Brands, Andrew Gibb et al. · Synthesis · 2003 · 103 citations

, , +9

Vortioxetine: First Global Approval

Andrew Gibb, Emma D. Deeks · Drugs · 2013 · 64 citations

, , +5

Practical Asymmetric Synthesis of a γ-Secretase Inhibitor Exploiting Substrate-Controlled Intramolecular Nitrile Oxide−Olefin Cycloaddition

Jeremy P. Scott, Steven F. Oliver, Karel M. J. Brands et al. · The Journal of Organic Chemistry · 2006 · 53 citations

, , +14

Development of a Phase Transfer Catalyzed Asymmetric Synthesis for an Estrogen Receptor Beta Selective Agonist

Jeremy P. Scott, Michael S. Ashwood, Karel M. J. Brands et al. · Organic Process Research & Development · 2007 · 38 citations

, , +8

1–5 of 14